Paige, EllieWelsh, JenniferAgostino, JasonCalabria, BiancaBanks, EmilyKorda, Rosemary2018-07-26Paige, Ellie, et al. "Socioeconomic variation in absolute cardiovascular disease risk and treatment in the Australian population." Preventive medicine (2018).0091-7435http://hdl.handle.net/1885/145652Cardiovascular disease (CVD), preventable through appropriate management of absolute CVD risk, disproportionately affects socioeconomically disadvantaged individuals. The aim of this study was to estimate absolute and relative socioeconomic inequalities in absolute CVD risk and treatment in the Australian population using cross-sectional representative data on 4,751 people aged 45-74 from the 2011-12 Australian Health Survey. Poisson regression was used to calculate prevalence differences (PD) and ratios (PR) for prior CVD, high 5-year absolute risk of a primary CVD event and guideline-recommended medication use, in relation to socioeconomic position (SEP, measured by education). After adjusting for age and sex, the prevalence of high absolute risk of a primary CVD event among those of low, intermediate and high SEP was 12.6%, 10.9% and 7.7% (PD, low vs. high=5.0 [95% CI: 2.3, 7.7], PR=1.6 [1.2, 2.2]) and for prior CVD was 10.7%, 9.1% and 6.7% (PD=4.0 [1.4, 6.6], PR=1.6 [1.1, 2.2]). The proportions using preventive medication use among those with high primary risk were 21.3%, 19.5% and 29.4% for low, intermediate and high SEP and for prior CVD, were 37.8%, 35.7% and 17.7% (PD=20.1 [9.7, 30.5], PR=2.1 [1.3, 3.5]). Proportions at high primary risk and not using medications among those of low, intermediate and high SEP were 10.6%, 8.8% and 4.7% and with prior CVD not using medications were 8.5%, 6.3% and 4.1%. Findings indicate substantial potential to prevent CVD and reduce inequalities through appropriate management of high absolute risk in the population.This work was supported by a National Health and Medical Research Council of Australia (NHMRC) Partnership Project (reference 1092674) and the NHMRC Centre for Research Excellence in Medicines and Ageing (reference 1060407). Emily Banks is supported by the NHMRC (reference 1042717).application/pdfhttp://www.sherpa.ac.uk/romeo/issn/0091-7435/..."Author's post-print on open access repository after an embargo period of 12 months" from SHERPA/RoMEO site (as at 26/07/18)Cardiovascular diseaseAbsolute riskSocioeconomic positionInequalities2018-0910.1016/j.ypmed.2018.07.011